1. Home
  2. BA vs BMY Comparison

BA vs BMY Comparison

Compare BA & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boeing Company (The)

BA

Boeing Company (The)

N/A

Current Price

$156.00

Market Cap

135.9B

Sector

Industrials

ML Signal

N/A

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

N/A

Current Price

$58.83

Market Cap

127.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BA
BMY
Founded
1916
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
135.9B
127.0B
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
BA
BMY
Price
$156.00
$58.83
Analyst Decision
Strong Buy
Hold
Analyst Count
27
28
Target Price
★ $233.35
$65.25
AVG Volume (30 Days)
★ 9.1M
9.0M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
N/A
★ 4.32%
EPS Growth
113.51
★ 178.46
EPS
N/A
★ 3.98
Revenue
★ $89,463,000,000.00
$48,194,000,000.00
Revenue This Year
$8.18
$4.23
Revenue Next Year
$12.98
N/A
P/E Ratio
★ N/A
$14.66
Revenue Growth
★ 34.50
N/A
52 Week Low
$158.92
$47.58
52 Week High
$254.35
$68.64

Technical Indicators

Market Signals
Indicator
BA
BMY
Relative Strength Index (RSI) 23.91 39.40
Support Level N/A $55.66
Resistance Level $233.91 $60.93
Average True Range (ATR) 4.85 1.71
MACD -0.83 -0.46
Stochastic Oscillator 3.22 13.93

Price Performance

Historical Comparison
BA
BMY

About BA Boeing Company (The)

Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: